Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-05-11 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2020-05-11 English
News release - English.pdf
Regulatory Filings
2020-05-11 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Blackhawk Growth Corp. It announces a material change related to the validation of Innovita's COVID-19 antibody test. The form is a regulatory filing used to disclose material changes to the company, typically short and focused on the announcement rather than detailed financial data or comprehensive reports. The document does not contain financial statements or detailed analysis but rather a description of the material change and related news release. Given the nature and length (4691 characters), it fits the definition of a Regulatory Filing (RNS) rather than a full report or other specific filing types.
2020-05-07 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the independent validation of Innovita's COVID-19 antibody test by the COVID-19 Testing Project. It discusses the test's performance, mentions FDA guidelines, and includes forward-looking statements. There is no indication of financial data, regulatory filings, or detailed reports such as annual or quarterly reports. The content is an announcement of a product validation and related information, typical of a general regulatory or corporate announcement rather than a financial or governance report. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2020-05-07 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report, which is a regulatory filing used to disclose material changes by a company. It announces the application to list warrants on the Canadian Securities Exchange, describing the nature of the change and relevant details. The document is short (2064 characters) and serves as a formal announcement of a material change rather than a full financial report or detailed analysis. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Blackhawk Growth Corp. has applied to list 46,000,000 share purchase warrants on the Canadian Securities Exchange. It discusses the listing application, trading symbol, and conditions for listing. There is no financial data, no detailed report, no audit, no management discussion, or other substantive financial or operational information. The document is an announcement about a capital market activity related to warrants listing, which fits the category of Capital/Financing Update (CAP). The document length is short (2911 characters), and it is not a report publication announcement or regulatory filing. Therefore, the best classification is Capital/Financing Update (CAP).
2020-05-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.